Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 29,671 | 13,940 | -1,065 | -6,196 | -4,461 |
| Depreciation Amortization | 82 | 46 | 21 | 66 | 47 |
| Income taxes - deferred | -2,915 | N/A | N/A | N/A | N/A |
| Accounts receivable | -10,509 | -5,743 | -924 | -122 | -39 |
| Other Working Capital | -19,782 | -15,715 | -746 | -818 | -277 |
| Other Operating Activity | 11,660 | 7,124 | 1,379 | 1,544 | 818 |
| Operating Cash Flow | $8,207 | $-349 | $-1,336 | $-5,525 | $-3,913 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -306 | -205 | -100 | -113 | -77 |
| Purchase Of Investment | -10,025 | -715 | -150 | -322 | -319 |
| Sale Of Investment | 3,260 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-7,070 | $-920 | $-250 | $-435 | $-397 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,658 | 20,384 | 19,520 | 5,496 | 5,496 |
| Other Financing Activity | -1,458 | -1,458 | -1,458 | 407 | 407 |
| Financing Cash Flow | $19,200 | $18,926 | $18,062 | $5,903 | $5,903 |
| Beginning Cash Position | 893 | 893 | 893 | 950 | 950 |
| End Cash Position | 21,230 | 18,550 | 17,369 | 893 | 2,544 |
| Net Cash Flow | $20,337 | $17,657 | $16,476 | $-57 | $1,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,207 | -349 | -1,336 | -5,525 | -3,913 |
| Capital Expenditure | -306 | -205 | -100 | -113 | -77 |
| Free Cash Flow | 7,902 | -554 | -1,436 | -5,638 | -3,990 |